Oramed Pharmaceuticals Inc

Penny Stocks Pharmaceutical Stocks Healthcare Stocks

$4.74

+0.07 (+1.50%)

As of Sep 20, 10:44 PM ET ·

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 3 50%

Sell 3 50%

Price Target

Analyst Price Target +101.5% upside

Low Target $5.95

Average Target $9.55

High Target $10.69

Current Price $4.74

Current
$4.74

Target
$9.55

$5.95 $9.55 avg $10.69

Scenario Analysis

Bear Case

$5.95

25.5%

Low target

Base Case

$9.55

+101.5%

Avg target

Bull Case

$10.69

+125.5%

High target

Risk/Reward

4.9x

Highly favorable

Price in Context

52-Week High

$5.47

-13.3% from high

52-Week Low

$2.09

+126.8% from low

Target vs 52W High

$9.55

+74.6% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	38	79%	$1,330.33	+13.7%
RDY Dr. Reddy's Laboratories	Strong Sell	45	31%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	71%	$299.55	+11.3%
MRK Merck & Co. Inc.	Buy	36	72%	$159.27	+5.5%
PFE Pfizer Inc.	Hold	36	39%	$33.90	+21.4%
BMY Bristol-Myers Squibb Co	Hold	35	43%	$174.50	+180.3%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-38.0%
ZTS Zoetis Inc	Hold	24	50%	$209.87	+188.0%